Maa: Armenia
Kieli: englanti
Lähde: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
ambroxol (ambroxol hydrochloride)
Arpimed LLC
R05CB06
ambroxol (ambroxol hydrochloride)
15mg/5ml
syrup
100ml glass bottle and measuring spoon
OTC
Registered
2016-06-08
1 / 6 AMBROTON SYRUP 15MG/5ML SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Ambroton 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml of syrup contains 3 mg ambroxol hydrochloride. For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Syrup Ambroton syrup is a clear or almost clear, colourless or almost colourless, slightly viscous syrup. 4. CLINICAL PARTICULARS _4.1 THERAPEUTIC INDICATION _ Acute and chronic respiratory diseases with the release of viscous mucus: acute and chronic bronchitis, pneumonia, chronic obstructive pulmonary disease, bronchial asthma with obstruction of sputum discharge, multiple bronchiectasis. _4.2 POSOLOGY AND METHOD OF ADMINISTRATION _ For oral use, regardless of the meals. Children 6-12 years: 5ml (15mg ambroxol) 2-3 times/day. The maximum dose - 45mg/day. After 2-3 days, if the child is getting better, the drug can be taken 2 times/day. Children 2-5 years: 2.5ml (7.5mg ambroxol) 3 times/day; the maximum dose - 22.5mg/day. After 2-3 days, if the child is getting better, the drug can be taken 2 times/day. Children under 2 years of age: the drug is contraindicated in children under 2 years of age. _Patients with impaired renal and hepatic function:_ Patients with impaired renal function or severe liver dysfunction should take the medication only as directed by a physician. Meanwhile the dose should be either reduced or the time between doses should be increased. _Missed dose:_ If the patient has forgotten to take medication or took an insufficient dose, he/she needs to continue taking the drug according to the dose regimen. If symptoms do not improve or worsen after 5 days of treatment, consult your doctor. 2 / 6 _4.3 CONTRAINDICATION _ Hypersensitivity to ambroxol or other components of the drug. First trimester of pregnancy. A rare hereditary intolerance to any component of Ambroton (see "Special precautions"). Children under 2 years of age. _Use with caution _in_ _II and III trimester of pregnancy, lactation, renal and/or hepatic insufficiency Lue koko asiakirja